MPO and inflammatory bowel disease: Intermittent targeting of MPO may offer an alternative (or adjunctive) approach to the raft of current immunosuppressive IBD treatment options; longer term MPO inhibition may impact on the adaptive response and have consequences on the host-defense against pathogenic microorganisms.